[1] |
ELSHEIKHA H M, MARRA C M, ZHU X Q. Epidemiology, pathophysiology, diagnosis, and management of cerebral toxoplasmosis[J]. Clin Microbiol Rev, 2021, 34(1):e00115-19.
|
[2] |
ZHOU P, CHEN Z G, LI H L, et al. Toxoplasma gondii infection in humans in China[J]. Parasit Vectors, 2011, 4:165.
|
[3] |
沈继龙, 余莉. 我国弓形虫病流行概况及防治基础研究进展[J]. 中国血吸虫病防治杂志, 2019, 31(1):71-76.SHEN J L, YU L. Prevalence and fundamental researches of prevention and treatment of toxo-plasmosis in China:an overview[J]. Chinese Journal of Schistosomiasis Control, 2019, 31(1):71-76.
|
[4] |
MAHMOUDVAND H, DEZAKI E S, SOLEIMANI S, et al. Seroprevalence and risk factors of Toxoplasma gondii infection among healthy blood donors in south-east of Iran[J]. Parasite Immunol, 2015, 37(7):362-367.
|
[5] |
KRISHNAMURTHY S, KONSTANTINOU E K, YOUNG L H, et al. The human immune response to Toxoplasma:Autophagy versus cell death[J]. PLoS Pathog, 2017, 13(3):e1006176.
|
[6] |
SCHLÜTER D, BARRAGAN A. Advances and challenges in understanding cerebral toxoplasmosis[J]. Front Immunol, 2019, 10:242.
|
[7] |
汪涛, 汤自豪. 弓形虫病:速殖子、包囊和卵囊的传播[J]. 中国人兽共患病学报, 2012, 28(11):1133-1136.WANG T, TANG Z H. Toxoplasmosis:the spread tachyzoites, cysts and oocysts[J]. Chinese Journal of Zoonoses, 2012, 28(11):1133-1136. (in Chinese)
|
[8] |
马巧妮, 王萌, 张海生, 等. 环境中弓形虫卵囊富集及检测技术的研究进展[J]. 中国兽医科学, 2021, 51(3):343-348.MA Q N, WANG M, ZHANG H S, et al. Research progress in enrichment and detection technologies for Toxoplasma gondii in the environment[J]. Chinese Veterinary Science, 2021, 51(3):343-348. (in Chinese)
|
[9] |
GOTTELAND C, GILOT-FROMONT E, AUBERT D, et al. Spatial distribution of Toxoplasma gondii oocysts in soil in a rural area:Influence of cats and land use[J]. Vet Parasitol, 2014, 205(3-4):629-637.
|
[10] |
尹创成, 朱兴全, 袁子国. 水源性弓形虫病的研究进展[J]. 中国畜牧兽医, 2011, 38(4):180-182.YIN C C, ZHU X Q, YUAN Z G. Research progress of water-borne toxoplasmosis[J]. China Animal Husbandry & Veterinary Medicine, 2011, 38(4):180-182. (in Chinese)
|
[11] |
杨俊. 常见食源性寄生虫病的防控措施[J]. 中国畜牧兽医文摘, 2017, 33(9):104-106.YANG J. Prevention and control measures of common food-borne parasitic diseases[J]. China Animal Husbandry and Veterinary Digest, 2017, 33(9):104-106. (in Chinese)
|
[12] |
OPSTEEGH M, MAAS M, SCHARES G, et al. Relationship between seroprevalence in the main livestock species and presence of Toxoplasma gondii in meat (GP/EFSA/BIOHAZ/2013/01) An extensive literature review. Final report[J]. EFSA Support Publicat, 2016, 13(2):996E.
|
[13] |
STELZER S, BASSO W, BENAVIDES SILVÁN J, et al. Toxoplasma gondii infection and toxoplasmosis in farm animals:Risk factors and economic impact[J]. Food Waterborne Parasitol, 2019, 15:e00037.
|
[14] |
PAN M, LYU C, ZHAO J L, et al. Sixty years (1957-2017) of research on toxoplasmosis in China-an overview[J]. Front Microbiol, 2017, 8:1825.
|
[15] |
HE J J, MA J, WANG J L, et al. iTRAQ-based quantitative proteomics analysis identifies host pathways modulated during Toxoplasma gondii infection in swine[J]. Microorganisms, 2020, 8(4):518.
|
[16] |
AEBERSOLD R, MANN M. Mass-spectrometric exploration of proteome structure and function[J]. Nature, 2016, 537(7620):347-355.
|
[17] |
YANG J, DU F, ZHOU X L, et al. Brain proteomic differences between wild-type and CD44- mice induced by chronic Toxoplasma gondii infection[J]. Parasitol Res, 2018, 117(8):2623-2633.
|
[18] |
ZHOU C X, ZHU X Q, ELSHEIKHA H M, et al. Global iTRAQ-based proteomic profiling of Toxoplasma gondii oocysts during sporulation[J]. J Proteom, 2016, 148:12-19.
|
[19] |
WANG Z X, ZHOU C X, ELSHEIKHA H M, et al. Proteomic differences between developmental stages of Toxoplasma gondii revealed by iTRAQ-based quantitative proteomics[J]. Front Microbiol, 2017, 8:985.
|
[20] |
PITTMAN K J, KNOLL L J. Long-term relationships:the complicated interplay between the host and the developmental stages of Toxoplasma gondii during acute and chronic infections[J]. Microbiol Mol Biol Rev, 2015, 79(4):387-401.
|
[21] |
LV L, WANG Y P, FENG W L, et al. iTRAQ-based differential proteomic analysis in Mongolian gerbil brains chronically infected with Toxoplasma gondii[J]. J Proteom, 2017, 160:74-83.
|
[22] |
HE J J, MA J, ELSHEIKHA H M, et al. Proteomic profiling of mouse liver following acute Toxoplasma gondii infection[J]. PLoS One, 2016, 11(3):e0152022.
|
[23] |
FERNANDES S, BRILHANTE-SIMÕES P, COUTINHO T, et al. Comparison of indirect and modified agglutination tests for detection of antibodies to Toxoplasma gondii in domestic cats[J]. J Vet Diagnost Investigat, 2019, 31(5):774-777.
|
[24] |
STAGGS S E, SEE M J, DUBEY J P, et al. Obtaining highly purified Toxoplasma gondii oocysts by a discontinuous cesium chloride gradient[J]. J Visual Experim, 2009, 33:e1402.
|
[25] |
HU R S, HE J J, ELSHEIKHA H M, et al. Transcriptomic profiling of mouse brain during acute and chronic infections by Toxoplasma gondii oocysts[J]. Front Microbiol, 2020, 11:570903.
|
[26] |
ZHOU D H, ZHAO F R, HUANG S Y, et al. Changes in the proteomic profiles of mouse brain after infection with cyst-forming Toxoplasma gondii[J]. Parasit Vectors, 2013, 6:96.
|
[27] |
ZHOU C X, XIE S C, LI M Y, et al. Analysis of the serum peptidome associated with Toxoplasma gondii infection[J]. J Proteom, 2020, 222:103805.
|
[28] |
CHEN X Q, ELSHEIKHA H M, HU R S, et al. Hepatic metabolomics investigation in acute and chronic murine toxoplasmosis[J]. Front Cell Infect Microbiol, 2018, 8:189.
|
[29] |
ZHOU C X, CONG W, CHEN X Q, et al. Serum Metabolic profiling of oocyst-induced Toxoplasma gondii acute and chronic infections in mice using mass-spectrometry[J]. Front Microbiol, 2018, 8:2612.
|
[30] |
MA J, CHEN T, WU S F, et al. iProX:an integrated proteome resource[J]. Nucleic Acids Res, 2019, 47(D1):D1211-D1217.
|
[31] |
SOTO A S, FENOY I M, SANCHEZ V R, et al. Toxoplasma gondii serine-protease inhibitor-1:A new adjuvant candidate for asthma therapy[J]. PLoS One, 2017, 12(10):e0187002.
|
[32] |
SUZUKI Y, ORELLANA M A, SCHREIBER R D, et al. Interferon-gamma:the major mediator of resistance against Toxoplasma gondii[J]. Science, 1988, 240(4851):516-518.
|
[33] |
SASAI M, PRADIPTA A, YAMAMOTO M. Host immune responses to Toxoplasma gondii[J]. Int Immunol, 2018, 30(3):113-119.
|
[34] |
MACMICKING J D. Interferon-inducible effector mechanisms in cell-autonomous immunity[J]. Nat Rev Immunol, 2012, 12(5):367-382.
|
[35] |
STEFFENS N, BEUTER-GUNIA C, KRAVETS E, et al. Essential role of mGBP7 for survival of Toxoplasma gondii infection[J]. mBio, 2020, 11(1):e02993-19.
|
[36] |
DEGRANDI D, KRAVETS E, KONERMANN C, et al. Murine guanylate binding protein 2(mGBP2) controls Toxoplasma gondii replication[J]. Proc Natl Acad Sci U S A, 2013, 110(1):294-299.
|
[37] |
KRAVETS E, DEGRANDI D, MA Q J, et al. Guanylate binding proteins directly attack Toxoplasma gondii via supramolecular complexes[J]. eLife, 2016, 5:e11479.
|
[38] |
SELLECK E M, FENTRESS S J, BEATTY W L, et al. Guanylate-binding protein 1(Gbp1) contributes to cell-autonomous immunity against Toxoplasma gondii[J]. PLoS Pathog, 2013, 9(4):e1003320.
|
[39] |
CAI Y, LEE J, WANG W, et al. Effect of Cd2+ on muscle type of creatine kinase:Inhibition kinetics integrating computational simulations[J]. Int J Biol Macromol, 2016, 83:233-241.
|
[40] |
LI Q J, FAN S, LI X Y, et al. Insights into the phosphoryl transfer mechanism of human ubiquitous mitochondrial creatine kinase[J]. Sci Rep, 2016, 6:38088.
|
[41] |
周永华, 范红结, 张英,等. 慢性弓形虫感染大鼠海马蛋白质组的研究[J]. 中国寄生虫学与寄生虫病杂志, 2013, 31(6):454-457.ZHOU Y H, FAN H J, ZHANG Y, et al. Proteomic study of the hippocampus tissue from rats with chronic Toxoplasma gondii infection[J]. Chinese Journal of Parasitology and Parasitic Diseases, 2013, 31(6):454-457. (in Chinese)
|
[42] |
ZHUANG G Z, KEELER B, GRANT J, et al. Carbonic anhydrase-8 regulates inflammatory pain by inhibiting the ITPR1-cytosolic free calcium pathway[J]. PLoS One, 2015, 10(3):e0118273.
|
[43] |
NAST R, CHOEPAK T, LVDER C G K. Epigenetic control of IFN-γ host responses during infection with Toxoplasma gondii[J]. Front Immunol, 2020, 11:581241.
|
[44] |
LANG C, HILDEBRANDT A, BRAND F, et al. Impaired chromatin remodelling at STAT1-regulated promoters leads to global unresponsiveness of Toxoplasma gondii-infected macrophages to IFN-γ[J]. PLoS Pathog, 2012, 8(1):e1002483.
|
[45] |
SEDWICK C. Tuning up STAT1[J]. PLoS Biol, 2015, 13(7):e1002201.
|
[46] |
GAY G, BRAUN L, BRENIER-PINCHART M P, et al. Toxoplasma gondii TgIST co-opts host chromatin repressors dampening STAT1-dependent gene regulation and IFN-γ-mediated host defenses[J]. J Exp Mede, 2016, 213(9):1779-1798.
|
[47] |
OLIAS P, ETHERIDGE R D, ZHANG Y, et al. Toxoplasma effector recruits the Mi-2/NuRD complex to repress STAT1 transcription and block IFN-γ-dependent gene expression[J]. Cell Host Micr, 2016, 20(1):72-82.
|